Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Fluad in Healthy Adults ≥65 Years
NCT01879540Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2013
- Primary completion
- Aug 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of influenza vaccine (surface antigen, inactivated, adjuvanted) in influenza, sponsored by Novartis. Started Jul 2013; status: completed.
02
Drugs
influenza vaccine (surface antigen, inactivated, adjuvanted)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01879540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01879540.